Theravance Biopharma, Inc.

NEW YORK STATE COMMON RETIREMENT FUND TBPH

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

12,310

Value ($000)

230

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	230	0.0%	12,310	12/31/2025
2025 Q3	11/3/2025	98	0.0%	6,710	9/30/2025
2025 Q2	10/8/2025	74	0.0%	6,710	6/30/2025
2025 Q1	10/8/2025	60	0.0%	6,710	3/31/2025
2024 Q4	10/8/2025	63	0.0%	6,710	12/31/2024
2024 Q3	10/8/2025	54	0.0%	6,710	9/30/2024
2024 Q2	10/8/2025	57	0.0%	6,710	6/30/2024
2024 Q1	10/8/2025	169	0.0%	18,801	3/31/2024
2023 Q4	10/8/2025	212	0.0%	18,877	12/31/2023
2023 Q3	10/8/2025	164	0.0%	18,994	9/30/2023
2023 Q2	10/8/2025	254	0.0%	24,506	6/30/2023
2023 Q1	10/8/2025	365	0.0%	33,671	3/31/2023
2022 Q4	10/8/2025	490	0.0%	43,654	12/31/2022
2022 Q3	11/8/2022	443	0.0%	43,659	9/30/2022
2022 Q2	8/4/2022	394	0.0%	43,518	6/30/2022
2022 Q1	7/1/2022	342	0.0%	35,817	3/31/2022
2021 Q4	2/2/2022	396	0.0%	35,806	12/31/2021
2021 Q3	11/2/2021	214	0.0%	28,951	9/30/2021
2021 Q2	8/2/2021	693	0.0%	47,694	6/30/2021
2021 Q1	5/11/2021	845	0.0%	41,400	3/31/2021
2020 Q4	2/8/2021	736	0.0%	41,400	12/31/2020
2020 Q3	11/5/2020	612	0.0%	41,400	9/30/2020
2020 Q2	8/7/2020	869	0.0%	41,400	6/30/2020
2020 Q1	5/6/2020	975	0.0%	42,200	3/31/2020
2019 Q4	2/5/2020	1,093	0.0%	42,200	12/31/2019